This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Citric acid cycle | |
|---|---|
| Name | Citric acid cycle |
| Othernames | Krebs cycle, tricarboxylic acid cycle, TCA cycle |
| Location | Mitochondrial matrix |
| Organisms | Most aerobic Escherichia coli, Saccharomyces cerevisiae, Homo sapiens |
| Discovered | 1937 |
| Discoverer | Hans Krebs |
Citric acid cycle
The citric acid cycle is a central metabolism pathway in aerobic Homo sapiens, Escherichia coli, and Saccharomyces cerevisiae that oxidizes acetyl groups to CO2 while generating reducing equivalents for oxidative phosphorylation and biosynthetic precursors. It operates in the mitochondrial matrix of eukaryotes and in the cytosol of many bacteria and interfaces with pathways such as glycolysis, β-oxidation, and gluconeogenesis. The cycle’s enzymes and intermediates are conserved across diverse taxa including Arabidopsis thaliana, Mycobacterium tuberculosis, and Bacillus subtilis, reflecting deep evolutionary roots.
The pathway begins with the condensation of an acetyl moiety from acetyl-CoA with oxaloacetate to form citrate, catalyzed in animals and many microbes by citrate synthase, and proceeds through a sequence of dehydrogenation, decarboxylation, hydration, and substrate-level phosphorylation reactions. Key outputs include reduced cofactors NADH and FADH2 that feed the electron transport chain and guanosine triphosphate (GTP) or ATP produced by substrate-level phosphorylation. The cycle provides carbon skeletons for synthesis of amino acids (e.g., via α-ketoglutarate and oxaloacetate), heme biosynthesis linked to porphyria-related pathways, and anaplerotic replenishment by enzymes such as pyruvate carboxylase. Regulation coordinates with hormonal signals (e.g., insulin, glucagon), nutrient states exemplified by fasting and feeding responses, and organ-specific demands in tissues like the liver, heart, and brain.
The sequence includes citrate, isocitrate, α-ketoglutarate, succinyl-CoA, succinate, fumarate, malate, and oxaloacetate. Enzymes include citrate synthase, aconitase, isocitrate dehydrogenase, α-ketoglutarate dehydrogenase complex, succinyl-CoA synthetase, succinate dehydrogenase (complex II of the mitochondrial respiratory chain), fumarase, and malate dehydrogenase. The α-ketoglutarate dehydrogenase complex resembles the pyruvate dehydrogenase multienzyme assembly characterized by work in Jakob Mayer-era biochemical research and later biochemical genetics in Heinz Holterhoff-like laboratories. Several intermediates are branching points: α-ketoglutarate links to glutamate and nitrogen metabolism via enzymes studied in Luria and Delbrück-style microbial genetics; succinyl-CoA feeds into porphyrin biosynthesis; and citrate exported to the cytosol supports fatty acid synthesis regulated in part by SREBP pathways observed in studies at institutions like Harvard University and the Max Planck Society.
Control is exerted at irreversible steps catalyzed by citrate synthase, isocitrate dehydrogenase, and the α-ketoglutarate dehydrogenase complex, with allosteric modulators such as ADP, NADH, and ATP influencing flux. Calcium signaling in muscle and neuronal tissues modulates dehydrogenase activity during exercise and synaptic activity documented in research from University of Oxford and Stanford University. Hormonal regulation by insulin and glucagon alters substrate availability via upstream pathways like glycolysis and lipolysis; nutrient-sensing systems including mTOR and AMPK indirectly affect cycle activity as shown in studies at Massachusetts Institute of Technology and University of Cambridge. Additionally, post-translational modifications, including phosphorylation and acetylation mediated by sirtuins studied at Salk Institute and Columbia University, remodel enzyme activity and metabolic rewiring in response to fasting and caloric restriction.
Electrons from NADH and FADH2 generated by the cycle are transferred to the mitochondrial electron transport chain complexes I and II, driving proton motive force generation across the inner mitochondrial membrane and ATP synthesis by ATP synthase. The stoichiometry linking acetyl-CoA oxidation to ATP yield has been quantified in bioenergetics studies by groups at California Institute of Technology and ETH Zurich. Interplay with glycolysis and the pentose phosphate pathway supplies NADPH and biosynthetic precursors; the cycle also contributes to one-carbon metabolism connected to folate cycles investigated at Johns Hopkins University and University of Toronto. Shuttle systems such as the malate-aspartate shuttle enable exchange of reducing equivalents between cytosol and mitochondrion, a mechanism explored in classic experiments at Max Planck Institute labs.
Variations include the glyoxylate cycle found in plants like Arabidopsis thaliana and bacteria such as Pseudomonas aeruginosa and Mycobacterium tuberculosis, which bypass decarboxylation steps via isocitrate lyase and malate synthase. Some anaerobic microbes operate reductive tricarboxylic acid cycles or reverse reactions for CO2 fixation, as described in studies of Aquifex aeolicus and Chlorobium tepidum. Horizontal gene transfer and gene duplication events traced in comparative genomics by teams at European Molecular Biology Laboratory have shaped enzyme repertoires across Proteobacteria, Firmicutes, and eukaryotic lineages. Evolutionary reconstructions link protometabolic networks to origins of life hypotheses investigated at Woods Hole Oceanographic Institution and Scripps Institution of Oceanography.
Defects in cycle enzymes cause inherited metabolic diseases, including mutations in fumarase linked to fumarase deficiency and tumor predisposition syndromes documented in clinical genetics centers like Mayo Clinic and Cleveland Clinic. Mutations in succinate dehydrogenase subunits associate with hereditary paraganglioma and pheochromocytoma described by investigators at Memorial Sloan Kettering Cancer Center and National Institutes of Health. Accumulation of oncometabolites such as succinate and fumarate contributes to pseudohypoxia and epigenetic dysregulation observed in studies at Dana-Farber Cancer Institute and Fred Hutchinson Cancer Center. Mitochondrial dysfunction involving TCA cycle perturbation features in neurodegenerative disorders researched at Karolinska Institutet and University College London.
The cycle was elucidated by Hans Krebs in 1937 using biochemical fractionation and tracer studies; subsequent structural and kinetic characterization used chromatography, spectrophotometry, and isotopic labeling techniques pioneered at Cambridge University and University of Oxford. Modern approaches employ mass spectrometry-based metabolomics, 13C flux analysis, cryo-electron microscopy of dehydrogenase complexes at EMBL facilities, and genome editing platforms like CRISPR-Cas9 developed at Broad Institute to probe function in model organisms including Mus musculus and Drosophila melanogaster. Landmark collaborations among institutions such as University of California, Berkeley, Imperial College London, and Weizmann Institute propelled understanding of regulatory networks and medical implications.